IM Cannabis Secures $225K Convertible Note Financing from…

Event summary

IM Cannabis Corp. closed a $225,000 convertible note financing with an institutional investor on July 1, 2026.
The note bears an 8% annual interest rate, rising to 14% in case of default, and is convertible into common shares.
Conversion price is set at the lower of $0.152 per share or 90% of the lowest daily volume-weighted average price over 20 trading days preceding conversion, with a floor of $0.0303.
The company issued warrants for up to 1,483,386 common shares at an exercise price of C$0.22 per share, exercisable immediately and expiring on July 1, 2031.

The big picture

This financing comes as IM Cannabis navigates a challenging regulatory environment in both Israel and Germany. The convertible note structure suggests a strategic move to extend runway while deferring immediate dilution concerns. The inclusion of warrants indicates potential upside for the institutional investor, aligning interests with the company's long-term growth prospects.

What we're watching

Liquidity Strategy: How IM Cannabis will deploy the $225,000 in proceeds for general corporate purposes and whether it can sustain its operations amid market volatility.
Shareholder Dynamics: The impact of potential share issuance on existing shareholders given the 4.99% beneficial ownership cap and the conversion mechanics.
Regulatory Compliance: The pace at which IM Cannabis can file and secure effectiveness of a resale registration statement with the SEC, given the agreed timelines.